- Report
- September 2024
- 183 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- March 2025
- 288 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- January 2025
- 315 Pages
Global
From €3797EUR$4,000USD£3,203GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- August 2023
- 120 Pages
Global
From €4414EUR$4,650USD£3,724GBP
- Report
- November 2021
- 120 Pages
Global
€2848EUR$3,000USD£2,402GBP
The Blood Substitute market is a subset of the larger Biomaterials market. Blood substitutes are artificial blood products that are designed to replace or supplement the use of human blood in medical treatments. These products are typically made from synthetic materials, such as polymers, and are designed to mimic the properties of human blood. Blood substitutes are used in a variety of medical applications, including transfusions, wound healing, and organ transplantation.
Blood substitutes offer a number of advantages over traditional blood transfusions, including a reduced risk of infection, improved shelf life, and the ability to be stored at room temperature. Additionally, blood substitutes can be used in cases where traditional blood transfusions are not available or are not suitable.
Some of the companies in the Blood Substitute market include Hemopure, Polyheme, Biopure, and Hemosol. These companies are focused on developing and commercializing blood substitutes for use in medical treatments. Show Less Read more